Market Access Transformation & Strategic Marketing Director

Boston, MA (Hybrid)

$208K/yr – $312K/yrDirector/Executive10+ years expFull time

Posted 2 months ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Lead Vertex market access initiatives across mega accounts, aligning branded/unbranded strategies with payer collaborations to optimize access and GTM planning.

  • Must-have: 10+ years in market access across payer, contracting, and MA
  • Standout: Cross-functional leadership in a matrix healthcare environment with VBC/OBA familiarity
  • Standout: Experience developing value frameworks and HEOR-integrated PVPs

Job Description

Responsibilities
  • Own and integrate Above Brand/Unbranded initiatives across the Vertex portfolio to advance customer interactions across the mega accounts and where applicable, broad, timely and sustainable access (including solution development, implementation, pull-through and measurement) alongside cross-functional leaders
  • In tandem with HEOR, define strategic payer collaborations (i.e. health equity, quality, population health, etc.) with mega accounts (non-branded) across the various therapeutic categories
  • Partner with the Access COE (data, analytics and insights) and CRM teams responsible for customer and data insight tracking across the broad and evolving access environment and Vertex portfolio
  • Evaluate alternative contracting frameworks such as VBC/OBA/Warranties that support the clinical profile of the product and allow for easy measurement of a desire outcome
  • Deliver impactful insights and analysis to shape GTM strategies
  • Own and manage market access assessments/environmental scans to inform LRP assumptions including the development of action plans to manage risks and opportunities
  • Provide an annual landscape assessment across all access channels to support brand planning and upcoming launches (Channels: Payers/Mega Accounts, IDNs, GPOs, SP/SDs, Pharmacy) as well as to establish prioritization of products across access channels
  • Partner with external agencies and vendors as needed and ensure approvals and budget allocation as required.
  • Establish a value framework and communication platform to deliver a portfolio of PVPs via HEOR integration leveraging IT capabilities; uniform look and feel and construct (PIE, PVP, etc..) to maximize customer engagements
Requirements
  • Bachelor’s degree in relevant field
  • Deep market access experience (10 yrs) across all channels including payer marketing, contracting, Account Management (Payer)
  • Typically requires 10-12 years of MA experience or the equivalent combination of education and experience
  • Expert knowledge of US healthcare system, including gov’t & commercial payers, hospitals, IDNs, policy, and the regulatory environment as well as the flow of funds
  • Previous strategic leadership experience in the pharmaceutical/biotech or healthcare industry; mega account experience
  • Understanding of alternative Value Base Contracts and evaluate various models and drive initiative and strategies to support OBA, warranty like models
  • Proven track record of meeting or exceeding objectives & goals, both as an individual and as part of a team
  • Excellent communication skills with experience presenting to customers and internal leadership
  • Demonstrated ability to successfully navigate cross-functional teams, influencing without direct authority, with the interpersonal skills to foster collaboration and succeed in a highly matrixed environment
  • Ability to perform in a fast-paced environment, manage multiple priorities simultaneously, and work effectively across cross-functional teams
  • Bachelor’s degree in relevant field
Nice To Have
  • Master’s Degree (preferred)
Benefits
  • From medical, dental and vision benefits to generous paid time off (including a week-long company shutdown in the Summer and the Winter)
  • educational assistance programs including student loan repayment, a generous commuting subsidy, matching charitable donations, 401(k) and so much more.
Vertex Pharmaceuticals logo

Vertex Pharmaceuticals

4.2 Glassdoor

Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide.Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards.Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/

Founded in 1989
Boston, Massachusetts, USA
6.1K employees (282 in marketing)
83% recommend to a friend
88% CEO approval

Traffic Signals

Monthly Visitors
340.5K
Monthly Google Ads Budget
$44.9K
Traffic Source Mix
Search
36.6%
Direct
38.5%
Referral
22.7%
Social
1%
Paid
1.1%

Headcount Trend

Current headcount: ~6.2K

Marketing Team

Marketing Team Size
258 (4% of company)
Median Career Experience
14 years
Median Tenure
3.8 years

Funding

Total Funding
$657.3M
Last Raise
$1.1M
Post IPO Secondary, 2 years ago

Funding History

  • Jul 2024
    Post IPO Secondary • $1.1M
  • May 2022
    Post IPO Equity • $50M
  • Dec 2009
    Post IPO Equity • $443M

Recent News